Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G

Medicine & Life Sciences

• Proteasome Inhibitors 79%
• Product Packaging 76%
• Virion 63%
• Primates 61%
• HIV-1 57%
• human APOBEC3G protein 52%
• vif Gene Products 33%
• benzyloxycarbonylleucyl-leucyl-leucine aldehyde 25%
• Antiviral Agents 24%
• Viral DNA 21%
• APOBEC-3G Deaminase 17%
• Primate Lentiviruses 15%
• Virus Assembly 12%
• Amino Acid Substitution 10%
• Proteasome Endopeptidase Complex 9%
• Down-Regulation 6%
• Viruses 6%
• Infections 4%

Agriculture & Biology

• proteasome inhibitors 100%
• virus assembly 95%
• Human immunodeficiency virus 1 81%
• virion 63%
• Primates 59%
• packaging 23%
• antiviral proteins 20%
• Lentivirus 18%
• mutants 15%
• proteasome endopeptidase complex 15%
• amino acid substitution 14%
• DNA 13%
• pathogenicity 10%
• proteins 8%
• viruses 8%
• degradation 8%
• synthesis 7%
• infection 6%
• cells 4%